Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNF112 antisense RNA 1 (RNF112-AS1)
- Target
- RNF112-AS1
- Molecular classification
- Long non-coding RNA, Antisense RNA
01
Overview
RNF112 antisense RNA 1 is a non-coding RNA transcribed in the antisense direction relative to the RNF112 gene. Antisense RNAs generally regulate gene expression by interacting with sense transcripts or influencing chromatin structure and transcriptional activity. RNF112-AS1, like other long antisense RNAs, may act in cis (locally on the same DNA locus) or trans (affecting genes elsewhere in the genome), but specific biological functions or disease associations for RNF112-AS1 were not found in the current search results. There are no drugs targeting RNF112-AS1, nor is it established as a protein-coding therapeutic target [3].
- Other names
- RNF112-AS1RNF112 antisense RNA 1
02
Mechanism of action
Antisense transcript-mediated RNA regulation (e.g., modulating mRNA stability, chromatin modification, or translation)
03
Biological functions
Regulation of gene expression in cis or trans (regulation depends on genomic context; antisense RNAs commonly regulate the expression of the sense gene or other targets)Potential roles in epigenetic regulation, transcriptional interference, and mRNA stability
04
Disease associations
Not specifically described for RNF112-AS1 in available search results. Other antisense RNAs and lncRNAs are broadly implicated in cancer, imprinting disorders, and gene regulation diseases
Beyond the preview
Go deeper on RNF112 antisense RNA 1 (RNF112-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNF112 antisense RNA 1 (RNF112-AS1).